Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.160
-0.380 (-10.73%)
At close: Mar 28, 2025, 4:00 PM
3.454
+0.294 (9.31%)
After-hours: Mar 28, 2025, 5:31 PM EDT

Artiva Biotherapeutics Revenue

In the year 2024, Artiva Biotherapeutics had annual revenue of $251.00K, down -99.25%.

Revenue (ttm)
$251.00K
Revenue Growth
-99.25%
P/S Ratio
158.79
Revenue / Employee
$2,820
Employees
89
Market Cap
76.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024251.00K-33.24M-99.25%
Dec 31, 202333.49M28.56M579.21%
Dec 31, 20224.93M2.93M146.30%
Dec 31, 20212.00M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition